Stellate Ganglion Block in Cerebral Palsy - Trial NCT06319508
Access comprehensive clinical trial information for NCT06319508 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Copka Sonpashan
Chao Phya Abhaibhubejhr Hospital
Timeline & Enrollment
N/A
Mar 01, 2024
Dec 01, 2024
Primary Outcome
Penetration-Aspiration Scale
Summary
The goal of this clinical trial is to test the efficacy of stellate ganglion block in
 children with cerebral palsy and dysphagia. The main question it aims to answer are:
 
 • Can stellate ganglion block improve the dysphagia of children with cerebral palsy?
 Participants were randomly divided into two groups, all provided with routine therapy. Based
 on this, the experimental group was given stellate ganglion block. The video fluoroscopic
 swallowing study was done to test the swallowing function before and after the study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06319508
Non-Device Trial